Genflow Biosciences plc (LON:GENF – Get Free Report) shares rose 3.4% during mid-day trading on Thursday . The company traded as high as GBX 1.99 and last traded at GBX 1.99. 2,461,160 shares traded hands during trading, an increase of 13% from the average daily volume of 2,170,370 shares. The stock had previously closed at GBX 1.93.
Genflow Biosciences Price Performance
The stock has a market capitalization of £11.27 million, a P/E ratio of -5.99 and a beta of 2.30. The stock’s fifty day moving average price is GBX 2.08 and its 200 day moving average price is GBX 2.06.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported GBX (0.33) earnings per share for the quarter. Genflow Biosciences had a negative net margin of 170.64% and a positive return on equity of 332.06%.
About Genflow Biosciences
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Further Reading
- Five stocks we like better than Genflow Biosciences
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
